OMER

SEC source: 0001415889-21-001949 · form4-04082021_040405.xml · nonDerivative · entry 2

Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,026,986

F1 · kind: Open market sale pursuant to a previously established Rule 10b5-1 trading plan adopted by the reporting person for expiring options. The trading schedule, including sale periods and the number of shares to be sold, was established at the time of the trading plan's adoption in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

F2 · price: This transaction was executed in multiple trades at prices ranging from $17.53 to $18.27; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

SEC source: 0001415889-21-001949 · form4-04082021_040405.xml · nonDerivative · entry 1

Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,064,393

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-21-000881 · form4-02232021_050201.xml · derivative · entry 6

JACOBSEN MICHAEL A · CIK 0001529087 · VP FINANCE AND CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,000

Underlying: Common Stock · 8,100 shares

Expires 2026-02-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to this option vested and became exercisable over 48 monthly installments, with a vesting commencement date of April 1, 2015.

SEC source: 0001415889-21-000881 · form4-02232021_050201.xml · nonDerivative · entry 4

JACOBSEN MICHAEL A · CIK 0001529087 · VP FINANCE AND CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,000

F1 · kind: Open market sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 3, 2020, at which time the trading schedule, including sale periods, price and the number of shares to be sold, was established in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

F3 · price: This transaction was executed in multiple trades at prices ranging from $23.12 to $23.39; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

SEC source: 0001415889-21-000881 · form4-02232021_050201.xml · nonDerivative · entry 3

JACOBSEN MICHAEL A · CIK 0001529087 · VP FINANCE AND CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,100

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-21-000889 · form4-02232021_030224.xml · derivative · entry 4

Demopulos Peter A MD · CIK 0001472161 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2021-05-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On February 22, 2021, the reporting person paid the exercise price and exercised options to purchase a total of 10,000 shares of the company's common stock. These shares have not been sold and are held for the account of the reporting person.

SEC source: 0001415889-21-000889 · form4-02232021_030224.xml · derivative · entry 3

Demopulos Peter A MD · CIK 0001472161 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2023-05-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On February 22, 2021, the reporting person paid the exercise price and exercised options to purchase a total of 10,000 shares of the company's common stock. These shares have not been sold and are held for the account of the reporting person.

SEC source: 0001415889-21-000889 · form4-02232021_030224.xml · nonDerivative · entry 2

Demopulos Peter A MD · CIK 0001472161 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 198,516

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-21-000889 · form4-02232021_030224.xml · nonDerivative · entry 1

Demopulos Peter A MD · CIK 0001472161 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 193,516

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-21-000881 · form4-02232021_050201.xml · derivative · entry 5

JACOBSEN MICHAEL A · CIK 0001529087 · VP FINANCE AND CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,100

Underlying: Common Stock · 10,000 shares

Expires 2026-02-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to this option vested and became exercisable over 48 monthly installments, with a vesting commencement date of April 1, 2015.

SEC source: 0001415889-21-000881 · form4-02232021_050201.xml · nonDerivative · entry 2

JACOBSEN MICHAEL A · CIK 0001529087 · VP FINANCE AND CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,000

F1 · kind: Open market sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 3, 2020, at which time the trading schedule, including sale periods, price and the number of shares to be sold, was established in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

F2 · price: This transaction was executed in multiple trades at prices ranging from $22.45 to $22.80; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

SEC source: 0001415889-21-000881 · form4-02232021_050201.xml · nonDerivative · entry 1

JACOBSEN MICHAEL A · CIK 0001529087 · VP FINANCE AND CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-21-000730 · form4-02172021_050202.xml · derivative · entry 2

Hood Leroy E. MD PhD · CIK 0001472162 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2021-05-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On February 12, 2021, the reporting person paid the exercise price and exercised options to purchase 5,000 shares of the company's common stock. These shares have not been sold and are held for the account of the reporting person.

SEC source: 0001415889-21-000730 · form4-02172021_050202.xml · nonDerivative · entry 1

Hood Leroy E. MD PhD · CIK 0001472162 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,390

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-21-000668 · form4-02122021_050201.xml · nonDerivative · entry 2

JACOBSEN MICHAEL A · CIK 0001529087 · VP FINANCE AND CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,000

F1 · kind: Open market sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 3, 2020, at which time the trading schedule, including sale periods, price and the number of shares to be sold, was established in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

F2 · price: This transaction was executed in multiple trades at prices ranging from $22.46 to $22.55; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

SEC source: 0001415889-21-000668 · form4-02122021_050201.xml · nonDerivative · entry 1

JACOBSEN MICHAEL A · CIK 0001529087 · VP FINANCE AND CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,900

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-21-000362 · form4-01212021_050101.xml · derivative · entry 3

JACOBSEN MICHAEL A · CIK 0001529087 · VP FINANCE AND CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,188

Underlying: Common Stock · 30,000 shares

Expires 2023-09-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 25% of the total number of shares subject to this option vested on September 3, 2014, and the remaining shares subject to the option vested and became exercisable in equal monthly installments over the 36 months following the initial vesting date.

F3 · derivative.exercise_date: On January 20, 2021, the reporting person paid the exercise price and exercised options to purchase 10,000 shares of the company's common stock. These shares have not been sold and are held for the account of the reporting person.

SEC source: 0001415889-21-000362 · form4-01212021_050101.xml · nonDerivative · entry 2

JACOBSEN MICHAEL A · CIK 0001529087 · VP FINANCE AND CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-21-000668 · form4-02122021_050201.xml · derivative · entry 3

JACOBSEN MICHAEL A · CIK 0001529087 · VP FINANCE AND CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,100

Underlying: Common Stock · 1,900 shares

Expires 2026-02-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to this option vested and became exercisable over 48 monthly installments, with a vesting commencement date of April 1, 2015.

SEC source: 0001415889-21-000362 · form4-01212021_050101.xml · nonDerivative · entry 1

JACOBSEN MICHAEL A · CIK 0001529087 · VP FINANCE AND CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,000

F1 · kind: Open market sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 3, 2020, at which time the trading schedule, including sale periods, price and the number of shares to be sold, was established in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

SEC source: 0001415889-21-000326 · form4-01152021_050101.xml · derivative · entry 3

Cable Thomas J. · CIK 0001472158 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2021-05-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-21-000326 · form4-01152021_050101.xml · nonDerivative · entry 2

Cable Thomas J. · CIK 0001472158 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,067

F1 · kind: Open market sale pursuant to a previously established Rule 10b5-1 trading plan adopted by the reporting person. The trading schedule, including sale periods and the number of shares to be sold, was established at the time of the trading plan's adoption in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

F2 · price: This transaction was executed in multiple trades at prices ranging from $16.45 to $17.47; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

SEC source: 0001415889-21-000326 · form4-01152021_050101.xml · nonDerivative · entry 1

Cable Thomas J. · CIK 0001472158 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,067

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-20-002497 · form4-10282020_091001.xml · derivative · entry 1

Cancelmo Peter B · CIK 0001778968 · VP, GEN. COUNSEL & CORP. SEC.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2030-10-25

F1 · derivative.exercise_date: This option shall vest and become exercisable over 48 equal monthly installments, with a vesting commencement date of October 26, 2020. Installments vest and become exercisable on each monthly anniversary thereafter.

SEC source: 0001415889-20-001537 · form4-06092020_080602.xml · derivative · entry 1

Cable Thomas J. · CIK 0001472158 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2030-06-04

F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2021 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date.

SEC source: 0001415889-20-001536 · form4-06092020_070606.xml · derivative · entry 1

Demopulos Peter A MD · CIK 0001472161 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2030-06-04

F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2021 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date.

SEC source: 0001415889-20-001535 · form4-06092020_070601.xml · derivative · entry 1

Hood Leroy E. MD PhD · CIK 0001472162 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2030-06-04

F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2021 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date.

SEC source: 0001415889-20-001534 · form4-06092020_070605.xml · derivative · entry 1

Aspiri Ray · CIK 0001472157 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2030-06-04

F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2021 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date.

SEC source: 0001415889-20-001533 · form4-06092020_070601.xml · derivative · entry 1

Shah Rajiv · CIK 0001642407 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2030-06-04

F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2021 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date.

SEC source: 0001415889-20-001532 · form4-06092020_070606.xml · derivative · entry 1

Bumol Thomas F. · CIK 0001767077 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2030-06-04

F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2021 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date.

SEC source: 0001415889-20-001531 · form4-06092020_070601.xml · derivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2030-06-04

F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2021 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date.

SEC source: 0001415889-20-001228 · form4-05152020_080502.xml · derivative · entry 3

Cable Thomas J. · CIK 0001472158 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · 5,000 shares

Expires 2020-05-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The options previously vested and became exercisable in equal annual installments over a three-year period, with a vesting commencement date of May 28, 2010. The options expire on May 27, 2020.

SEC source: 0001415889-20-001228 · form4-05152020_080502.xml · nonDerivative · entry 2

Cable Thomas J. · CIK 0001472158 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,067

F1 · kind: Open market sale pursuant to a previously established Rule 10b5-1 trading plan adopted by the reporting person. The trading schedule, including sale periods and the number of shares to be sold, was established at the time of the trading plan's adoption in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

F2 · price: This transaction was executed in multiple trades at prices ranging from $13.99 to $15.15; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

SEC source: 0001415889-20-001228 · form4-05152020_080502.xml · nonDerivative · entry 1

Cable Thomas J. · CIK 0001472158 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,067

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-20-000797 · form4-03172020_050302.xml · derivative · entry 2

Hood Leroy E. MD PhD · CIK 0001472162 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2020-05-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: On March 13, 2020, the reporting person paid the exercise price and exercised options to purchase 5,000 shares of the company's common stock. These shares have not been sold and are held for the account of the reporting person. The options previously vested and became exercisable in equal installments over a three-year period, with a vesting commencement date of May 28, 2010.

SEC source: 0001415889-20-000797 · form4-03172020_050302.xml · nonDerivative · entry 1

Hood Leroy E. MD PhD · CIK 0001472162 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,390

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-20-000610 · form4-03032020_060308.xml · derivative · entry 1

Cancelmo Peter B · CIK 0001778968 · VP, GEN. COUNSEL & CORP. SEC.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2030-02-28

F1 · derivative.exercise_date: This option shall vest and become exercisable over 48 equal monthly installments, with a vesting commencement date of March 1, 2020. Installments vest and become exercisable on each monthly anniversary thereafter.

SEC source: 0001415889-20-000612 · form4-03032020_060306.xml · derivative · entry 1

Demopulos Gregory A MD · CIK 0001472160 · Director · CHIARMAN, CEO & PRESIDENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 450,000

Underlying: Common Stock · 450,000 shares

Expires 2030-02-28

F1 · derivative.exercise_date: This option shall vest and become exercisable over 48 equal monthly installments, with a vesting commencement date of March 1, 2020. Installments vest and become exercisable on each monthly anniversary thereafter.

SEC source: 0001415889-20-000611 · form4-03032020_060312.xml · derivative · entry 1

JACOBSEN MICHAEL A · CIK 0001529087 · VP FINANCE AND CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2030-02-28

F1 · derivative.exercise_date: This option shall vest and become exercisable over 48 equal monthly installments, with a vesting commencement date of March 1, 2020. Installments vest and become exercisable on each monthly anniversary thereafter.

SEC source: 0000899243-20-004400 · doc4.xml · derivative · entry 2

Zumwalt Kurt · CIK 0001803266 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,750

Underlying: Common Stock · 11,750 shares

Expires 2030-02-09

F2 · derivative.exercise_date: This option vests and becomes exercisable over 12 equal monthly installments, with a vesting commencement date of February 10, 2020. Installments vest and become exercisable on each monthly anniversary thereafter.

SEC source: 0000899243-20-004400 · doc4.xml · derivative · entry 1

Zumwalt Kurt · CIK 0001803266 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2030-02-09

F1 · derivative.exercise_date: This option vests and becomes exercisable in equal annual installments over a three-year period beginning on the first anniversary of the date of grant.

SEC source: 0000899243-19-029502 · doc4.xml · derivative · entry 2

Hood Leroy E. MD PhD · CIK 0001472162 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2019-12-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: On December 14, 2019, the reporting person paid the exercise price and exercised options to purchase 10,000 shares of the company's common stock. These shares have not been sold and are held for the account of the reporting person. The options previously vested and became exercisable in equal annual installments over a three-year period, with a vesting commencement date of December 15, 2010.

SEC source: 0000899243-19-029502 · doc4.xml · nonDerivative · entry 1

Hood Leroy E. MD PhD · CIK 0001472162 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,390

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000899243-19-029501 · doc4.xml · derivative · entry 3

Demopulos Peter A MD · CIK 0001472161 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,334 shares

Expires 2019-12-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: On December 14, 2019, the reporting person paid the exercise price and exercised options to purchase 3,334 shares of the company's common stock. These shares have not been sold and are held for the account of the reporting person. The options previously vested and became exercisable in equal annual installments over a three-year period, with a vesting commencement date of December 15, 2010.

SEC source: 0000899243-19-029501 · doc4.xml · nonDerivative · entry 1

Demopulos Peter A MD · CIK 0001472161 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 188,516

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000899243-19-028629 · doc4.xml · derivative · entry 3

Cable Thomas J. · CIK 0001472158 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2019-12-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The options previously vested and became exercisable in equal annual installments over a three-year period, with a vesting commencement date of December 15, 2010. The options expire on December 14, 2019.

SEC source: 0000899243-19-028629 · doc4.xml · nonDerivative · entry 2

Cable Thomas J. · CIK 0001472158 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,067

F1 · kind: Open market sale pursuant to a previously established Rule 10b5-1 trading plan adopted by the reporting person. The trading schedule, including sale periods and the number of shares to be sold, was established at the time of the trading plan's adoption in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The reporting person's Rule 10b5-1 trading plan further provides for the exercise and sale of up to 5,000 shares underlying stock options that will expire in May 2020.

F2 · price: This transaction was executed in multiple trades at prices ranging from $14.17 to $14.56; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

SEC source: 0000899243-19-028629 · doc4.xml · nonDerivative · entry 1

Cable Thomas J. · CIK 0001472158 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,067

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000899243-19-025638 · doc4.xml · nonDerivative · entry 1

Cable Thomas J. · CIK 0001472158 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,067

F1 · kind: Open market sale pursuant to a previously established Rule 10b5-1 trading plan adopted by the reporting person. The trading schedule, including sale periods and the number of shares to be sold, was determined at the time of the trading plan's adoption in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The reporting person's Rule 10b5-1 trading plan further provides for the exercise and sale of up to 10,000 shares underlying outstanding stock options that will expire in December 2019 and 5,000 shares underlying stock options that will expire in May 2020.

F2 · price: This transaction was executed in multiple trades at prices ranging from $14.64 to $15.44; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

SEC source: 0000899243-19-016506 · doc4.xml · derivative · entry 1

Cancelmo Peter B · CIK 0001778968 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2029-06-09

F1 · derivative.exercise_date: This option vests and becomes excisable over 48 equal monthly installments, with a vesting commencement date of June 10, 2019. Installments vest and become exercisable on each monthly anniversary thereafter.